Comparison of different agents and doses of anti-vascular endothelial growth factors (aflibercept, bevacizumab, conbercept, ranibizumab) versus laser for retinopathy of prematurity: A network meta-analysis
Amparo Ortiz-Seller, P. Martorell, Honorio Barranco, Isabel Pascual-Camps, Esteban Morcillo, J.L. Ortiz
Topics & Concepts
RanibizumabAfliberceptBevacizumabMedicineRetinopathy of prematurityOphthalmologyMeta-analysisInternal medicineChemotherapyPregnancyGestational ageBiologyGeneticsRetinopathy of Prematurity StudiesNeonatal Respiratory Health ResearchNeonatal and fetal brain pathology